Full Version
|
Search
The Irish Medicines Board - www.imb.ie
Home
About Us
Consultation
Events
Glossary
Legislation
Links
News
Publications
Recruitment
Register
Safety & Quality
Human Medicines
Veterinary
Medical Devices
Blood, Tissues, Organs
Cosmetics
Patients & Public
Home
»
Publications
»
Exenatide (Byetta) – Risk of severe pancreatitis and warnings regarding use in renal impairment
Your Selection
[x]
Letter
: E
[x] Remove All Filters
By Product
Human medicines (12)
By Audience / Stakeholder Group
Healthcare professionals (11)
Industry (1)
By Document Type
Direct Healthcare Professional Communication (10)
Forms & Templates (1)
Safety Updates & Reports (1)
By Service
Licensing – Medicines (1)
Exenatide (Byetta) – Risk of severe pancreatitis and warnings regarding use in renal impairment
05 June 2009
Tags:
Human medicines
Healthcare professionals
Safety Updates & Reports
2009
Exenatide (Byetta) - Risk of severe pancreatitis and warnings regarding use in renal impairment
« View Publications List
Provide Feedback
RSS Feeds
IMB Publications RSS Feed